Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Oct;216(4):389–400. doi: 10.1097/00000658-199210000-00001

Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.

H Buchwald 1, C T Campos 1, J P Matts 1, L L Fitch 1, J M Long 1, R L Varco 1
PMCID: PMC1242636  PMID: 1417188

Abstract

The Program on the Surgical Control of the Hyperlipidemias (POSCH) provided the clearest and the most convincing evidence supporting the beneficial effects of cholesterol lowering in hypercholesterolemic survivors of a myocardial infarction. In POSCH, 78 of the 838 patients (9.3%) were women, with 32 randomized to the diet-control group and 46 to the diet plus partial ileal bypass surgery-intervention group. At 5 years, the mean per cent change from baseline was -23.9% for total plasma cholesterol (p < 0.0001), -36.1% for low-density lipoprotein cholesterol (p < 0.0001), and +8.5% for high-density lipoprotein cholesterol (p = not significant). Because of the small number of women, no statistically significant changes in clinical event rates were observed between the control and the surgery groups. A comparison of 162 coronary arteriography film pairs in the POSCH women, between baseline and 3, 5, 7, and 10 years, consistently showed less disease progression in the surgery group (p = 0.013 for combined assessments of the baseline to the longest follow-up film). Because the lipid and coronary arteriography findings in the POSCH women paralleled these findings in the total POSCH population and in the POSCH men, and because the arteriography changes in POSCH have previously been demonstrated to be statistically significant surrogate end points for certain clinical events and predictors of overall and atherosclerotic coronary heart disease mortality rates, we conclude that the lipid modification achieved in the POSCH women by partial ileal bypass reduced their atherosclerosis progression. The POSCH findings in women support the aggressive treatment of hyperlipidemia in the general management of atherosclerosis in women.

Full text

PDF
389

Images in this article

395FIG. 3.
on p.395

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUCHWALD H. LOWERING OF CHOLESTEROL ABSORPTION AND BLOOD LEVELS BY ILEAL EXCLUSION. EXPERIMENTAL BASIS AND PRELIMINARY CLINICAL REPORT. Circulation. 1964 May;29:713–720. doi: 10.1161/01.cir.29.5.713. [DOI] [PubMed] [Google Scholar]
  2. Blankenhorn D. H., Johnson R. L., Nessim S. A., Azen S. P., Sanmarco M. E., Selzer R. H. The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. Control Clin Trials. 1987 Dec;8(4):356–387. doi: 10.1016/0197-2456(87)90156-5. [DOI] [PubMed] [Google Scholar]
  3. Brensike J. F., Levy R. I., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W., Moriarty D. J. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):313–324. doi: 10.1161/01.cir.69.2.313. [DOI] [PubMed] [Google Scholar]
  4. Buchwald H., Fitch L. L., Campos C. T. Partial ileal bypass in the treatment of hypercholesterolemia. J Fam Pract. 1992 Jul;35(1):69–76. [PubMed] [Google Scholar]
  5. Buchwald H., Fitch L., Moore R. B. Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease. Control Clin Trials. 1982 Sep;3(3):271–283. doi: 10.1016/0197-2456(82)90011-3. [DOI] [PubMed] [Google Scholar]
  6. Buchwald H., Matts J. P., Fitch L. L., Varco R. L., Campbell G. S., Pearce M., Yellin A., Smink R. D., Jr, Sawin H. S., Jr, Campos C. T. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group. J Clin Epidemiol. 1989;42(12):1111–1127. doi: 10.1016/0895-4356(89)90109-1. [DOI] [PubMed] [Google Scholar]
  7. Buchwald H., Matts J. P., Hansen B. J., Long J. M., Fitch L. L. Program on Surgical Control of the Hyperlipidemias (POSCH): recruitment experience. Control Clin Trials. 1987 Dec;8(4 Suppl):94S–104S. doi: 10.1016/0197-2456(87)90012-2. [DOI] [PubMed] [Google Scholar]
  8. Buchwald H., Stoller D. K., Campos C. T., Matts J. P., Varco R. L. Partial ileal bypass for hypercholesterolemia. 20- to 26-year follow-up of the first 57 consecutive cases. Ann Surg. 1990 Sep;212(3):318–331. doi: 10.1097/00000658-199009000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Buchwald H., Varco R. L., Matts J. P., Long J. M., Fitch L. L., Campbell G. S., Pearce M. B., Yellin A. E., Edmiston W. A., Smink R. D., Jr Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med. 1990 Oct 4;323(14):946–955. doi: 10.1056/NEJM199010043231404. [DOI] [PubMed] [Google Scholar]
  10. Carlson L. A., Danielson M., Ekberg I., Klintemar B., Rosenhamer G. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis. 1977 Sep;28(1):81–86. doi: 10.1016/0021-9150(77)90201-5. [DOI] [PubMed] [Google Scholar]
  11. Dorr A. E., Gundersen K., Schneider J. C., Jr, Spencer T. W., Martin W. B. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978 Jan;31(1):5–14. doi: 10.1016/0021-9681(78)90076-0. [DOI] [PubMed] [Google Scholar]
  12. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  13. Gidez L. I., Miller G. J., Burstein M., Slagle S., Eder H. A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982 Nov;23(8):1206–1223. [PubMed] [Google Scholar]
  14. Hatch F. T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 1968;6:1–68. [PubMed] [Google Scholar]
  15. Kane J. P., Malloy M. J., Ports T. A., Phillips N. R., Diehl J. C., Havel R. J. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990 Dec 19;264(23):3007–3012. [PubMed] [Google Scholar]
  16. Kannel W. B., Castelli W. P. The Framingham study of coronary disease in women. Med Times. 1972 May;100(5):173–passim. [PubMed] [Google Scholar]
  17. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  19. Matts J. P., Buchwald H., Fitch L. L., Campos C. T., Varco R. L., Campbell G. S., Pearce M. B., Yellin A. E., Edmiston W. A., Smink R. D., Jr Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group. Control Clin Trials. 1991 Apr;12(2):314–339. doi: 10.1016/0197-2456(91)90028-k. [DOI] [PubMed] [Google Scholar]
  20. Palca J. NIH unveils plan for women's health project. Science. 1991 Nov 8;254(5033):792–792. doi: 10.1126/science.1948061. [DOI] [PubMed] [Google Scholar]
  21. ROSE G. A., THOMSON W. B., WILLIAMS R. T. CORN OIL IN TREATMENT OF ISCHAEMIC HEART DISEASE. Br Med J. 1965 Jun 12;1(5449):1531–1533. doi: 10.1136/bmj.1.5449.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sandler H., Dodge H. T. The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J. 1968 Mar;75(3):325–334. doi: 10.1016/0002-8703(68)90089-6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES